focus -WSS

focus

author：focus 2025-09-29 01:29:24 - browse：8

1:31Police lights on a street at night.STOCK PHOTO/Getty Images

Four people are dead and two are hospitalized in stable condition following a mass shooting late Monday night in the Kingsessing neighborhood of Philadelphia, officials said.

Philadelphia Police Commissioner Danielle M. Outlaw said two people were in custody: a 40-year-old man who is believed to be the shooter, and a second person who authorities believe picked up a firearm and started shooting at the suspect. Police said the suspect was wearing a bulletproof vest and had multiple magazines, and was firing randomly.

"Officers responded quickly and showed bravery and courage," Outlaw said during a press conference, adding, "Their actions prevented potentially more victims."

MORE: 30 injured, 2 fatally, in Baltimore mass shooting: 'It was a war zone'

Police received reports of gunfire in the area behind Chester Street around 8:56 p.m. ET. Officers responded to the scene and found the gunshot victims, who have not yet been identified.

Of the four deceased victims, three are between 20 and 59 years old, while the fourth victim may be between 16 and 21, authorities said. All are male. The two stable victims, who are also male, are children ages 2 and 13.

This is a developing story. Please check back for updates.

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Kaiser's Risant Health gobbled up Geisinger. Who is next?

knowledge

WSS

Vertex cell therapy lets patients with type 1 diabetes stop insulin

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

STAT wants to know your pick for a great summer read or listen

Undocumented workers face uncertainty as immigration law takes effect in Florida

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

focus

focus

MORE: 30 injured, 2 fatally, in Baltimore mass shooting: 'It was a war zone'

hotspot

Affirmative action in medical school literally saved lives

At ASCO, AstraZeneca reports strong data for breast cancer drug

After affirmative action ruling, medical educators look to 'holistic review'

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

The cancer drug shortage isn’t new — and neither are the solutions

What affirmative action's end means to a medical student

Medical records are filled with copy

STAT wants to know your pick for a great summer read or listen

In age of alternative facts, a scholarly course on calling out crap

ASCO: Palliative care found as helpful given virtually as in person

focus

Security flaws in third

BMI, flaws aside, is found to be useful estimate of body fat in youth

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

Intellia reports positive results for its CRISPR

A letter from the executive editor: The 2023 STATUS List

Dexcom's push to bring CGM to type 2 diabetes patients

entertainment

knowledge

entertainment

leisure time